WEST HOLLYWOOD, Calif., Sept. 24, 2018 /PRNewswire/ — OncoTracker, Inc. announced that its Chief Executive Officer, James Kuo, MD, MBA, has been invited to speak at the 20th Annual SoCalBio Conference taking place on Friday, September 28, 2018. Dr. Kuo will provide an update on OncoTracker’s recent business activities and answer questions about the company. The conference will be held at the Westin Hotel in Long Beach, California. More information can be found at www.socalbio.org.
OncoTracker, Inc. is a West Hollywood-based oncology company with exclusive rights to a novel blood biomarker that is the target of several multiple myeloma therapies in clinical development. OncoTracker utilizes this biomarker to monitor the tumor burden and predict the therapeutic outcome of multiple myeloma patients. In addition, OncoTracker believes this biomarker has clinical relevancy in chronic lymphocytic leukemia, B-cell lymphoma and potentially other solid tumors. OncoTracker further possesses intellectual property related to two multiple myeloma therapies in clinical trials.
SoCalBio is a nonprofit, member-supported trade association that promotes bioscience research, development, manufacturing, job creation and overall economic growth in the Greater Los Angeles region. The Council’s programs help local firms gain access to capital, potential partners and business support services. The annual SoCalBio Conference has grown to become the region’s premier showcase for emerging life-science companies and technologies. In addition to plenary sessions, business roundtables, and therapeutic workshops, this conference will feature at least 24 company presentations showcasing the strength and future of the bioscience industry in Los Angeles/Orange County and neighboring communities. SoCalBio also promotes technology transfer and workforce training, while informing policymakers and the public at-large about the benefits of the region’s life-science industry. More information about SoCalBio is available at www.socalbio.org.